Dottorato in Fisiopatologia Medica

Contatti

Attività di ricerca

Attended PhD classes (1st year)

Approaches to scientific reasearch

May 16, 2023 - Fitting regression models: interpretation of regression coefficients, uncertainty measures and hypothesis testing - Prof.ssa  M. Maule

July 3, 2023 - Scientific presentations - Prof.ssa B. Bussolati

July 11, 2023 - How to write a scientific paper - Prof.ssa R. Granata

July 13, 2023 - How to set up an in vivo experimental model - Prof.ssa S. Bruno

July 20, 2023 - Regression models: from the linear model to the generalised linear models.
Interpretation of interactions between predictors - Prof.ssa M. Maule

Pathophysiological basis of diseases

May 18, 2023 - Etiopathogenesis of diabetic retinopathy - Prof. M. Porta

June 27, 2023 - Physiopathology of diabetic nephropathy - Prof.ssa G. Gruden

July 4, 2023 - Update on physiology of hypertension - Prof. F. Veglio

PhD seminars

April 26, 2023 - Cardioprotection through pharmacological conditioning – Prof.ssa Ioanna Andreadou, Visiting Professor, University of Athens, Greece

E-learning courses

February 1 - May 18, 2023 “Bibliography and bibliometrics like pros: stay up to date and develop literature syntheses in the biomedical domain".

Seminaries

September 20, 2023 - Droplet Digital PCR Conference, Turin, Italy

May 31, 2023 - Droplet Digital PCR Conference:  ddPCR for a Multiplex of Reasons, Milan, Italy

Congresses

June 12-15, 2023 - EACR 2023 Congress: Innovative Cancer Science, Turin, Italy

May 16-18, 2023 - EMBL in Italy 2023: Chance and necessity-the indispensable role of curiosity-driven life sciences, Turin, Italy

November 16-18, 2022 - 62nd annual Meeting of the Italian Cancer Society, Venice, Italy

Publications

Journal papers

Yakymiv Y., Marchisio S., Ortolan E., Bracci C., Senetta R., Rumore M. R., Tampieri C., Fia M., Ribero S., Funaro A., Quaglino P. CD39/CD73 dysregulation and adenosine metabolism contribute to T cell immunosuppression in patients with Sézary syndrome. Blood 2023; 141 (1): 111–116.

Journal abstracts

Marchisio S., Ricci A.A, Russo A., Berrino E., Ortolan E., Matullo G., Marchiò C., Senetta R., Funaro A., Quaglino P. Adjuvant therapy in cutaneous melanoma: monitoring disease recurrence by circulating tumor DNA. (2023), Abstracts. Mol Oncol, 17

Yakymiv Y., Marchisio S., Ortolan E., Pullano V., Leso C., Senetta R., Fia M., Quaglino P., Funaro A. The CD39/CD73/adenosine pathway contributes to generating an immunosuppressive microenvironment in patients with Sézary Syndrome. (2023), Abstracts. Mol Oncol, 17: 585.

Poster presentations

Marchisio S., Ricci A.A, A. Russo, Berrino E., Ortolan E., Matullo G., Marchiò C., Senetta R., Funaro A., Quaglino P. Adjuvant therapy in cutaneous melanoma: monitoring disease recurrence by circulating tumor DNA. EACR 2023 Congress

Yakymiv Y., Marchisio S., Ortolan E., Pullano V., Leso C., Senetta R., Fia M., Quaglino P., Funaro A. The CD39/CD73/adenosine pathway contributes to generating an immunosuppressive microenvironment in patients with Sézary Syndrome. EACR 2023 Congress

Marchisio S., Yakymiv Y., Fissolo G., Augeri S., Ortolan E., Funaro A. CD157 is a promising marker for the design of tailored therapies in patients with malignant pleural mesothelioma. SIC 2022 Congress

Ortolan E., Yakymiv Y., Marchisio S., Bracci C., Cattaneo A., Leso C., Senetta R., Rumore M. R., Tampieri C., Fia M., Ribero S., Quaglino P., Funaro A. Dysregulation of the CD39/CD73/adenosinergic axis contributes to immunesuppression in Sezary Syndrome. SIC 2022 Congress